Filing Flows

Filing Flows › Industrials › Azenta (AZTA)

Azenta (AZTA) earnings and revenue breakdown

Latest: Q3 FY26 · 10-Q filed Aug 6, 2026 · Azenta (AZTA) Q3 FY26 earnings results →

Q3 FY26 Revenue up 12% year over year to $161M · 2¢ of every $1 of revenue kept as net profit · operating margin -2.6%

Azenta made $161M in Q3 FY26 (+12% Y/Y): Sample Management Solutions $88.3M, Multiomics $72.9M. Operating margin -2.6%, net earnings $2.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 6, 2026.

Revenue$161M
Year over year+12%
Operating margin-2.6%
Net earnings$2.5M
Operating cash flow$1.4M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $161.2M in Q3 FY26, up 12% year over year and up 11% from the previous quarter. Multiomics was the largest line at 45% of revenue. Sample Repository Services added $8.7M year over year (up 27%), 50% of the total change.

Gross margin was 44.9%, down 1.3 points from Q3 FY25. Operating costs exceeded revenue by $4.2M, an operating margin of -2.6%. Operating expenses grew 12% against revenue growth of 12%. The fastest-growing cost line was Research & development (+19%). Net earnings were $2.5M. The effective tax rate was 49.2%. Non-operating items added $9.0M, 186% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $1.4M (down 94% year over year), 59% of net earnings. Non-cash charges added back $13.6M of depreciation and amortization and $4.8M of share-based compensation. Working capital and other items used $19.4M. Capital expenditures of $6.6M exceeded it, leaving free cash flow of −$5.2M.

Quarterly history

Azenta revenue by quarterAzenta revenue by quarter$151MQ4 FY24$143MQ2 FY25$144MQ3 FY25$159MQ4 FY25$149MQ1 FY26$145MQ2 FY26$161MQ3 FY26
Azenta net earnings by quarterAzenta net earnings by quarter−$6.6MQ4 FY24−$40.5MQ2 FY25−$52.8MQ3 FY25$50.9MQ4 FY25−$15.4MQ1 FY26−$161MQ2 FY26$2.5MQ3 FY26
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 FY2610-QAug 6, 2026$161M+12%-2.6%$2.5M$1.4M
Q2 FY2610-QMay 8, 2026$145M+1%-114.5%−$161M$13.5M
Q1 FY2610-QFeb 5, 2026$149M+0.8%-4.9%−$15.4M$20.8M
Q4 FY2510-KDec 4, 2025$159M+6%1.2%$50.9M$2.2M
Q3 FY2510-QAug 6, 2025$144M-0.3%-0.5%−$52.8M$25.8M
Q2 FY2510-QMay 9, 2025$143M+5%-11.3%−$40.5M$14.4M
Q4 FY2410-KNov 27, 2024$151M-13%-3.1%−$6.6M$17.7M

Charts

Azenta: revenue growth, year over year and quarter over quarterAzenta: revenue growth, year over year and quarter over quarterY/YQ/Q-13%Q4 FY24+5%-5%Q2 FY250%+0%Q3 FY25+6%+11%Q4 FY25+1%-7%Q1 FY26+1%-3%Q2 FY26+12%+11%Q3 FY26
Latest (Q3 FY26): Y/Y +12%, Q/Q +11%.
Azenta: where the cash came from (+) and went (−), TTM to Q3 FY26Azenta: where the cash came from (+) and went (−), TTM to Q3 FY26Cash drawn (+) / kept (−)$89.1MBuybacks−$50.0MOperating cash flow$38.0MOther investing−$33.2MCapital spending−$28.1MAcquisitions−$11.2MExchange rates−$3.5MTaxes on employees’ shares−$2.5MShares issued$2.4MNet borrowing (+) / repaid (−)−$983K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Azenta: profit against cash, quarter by quarterAzenta: profit against cash, quarter by quarterNet incomeOperating cash flow−$6.6M$17.7MQ4 FY24−$11.0M$29.8MQ1 FY25−$47.7M$14.4MQ2 FY25−$48.0M$25.8MQ3 FY25$50.9M$2.2MQ4 FY25−$15.4M$20.8MQ1 FY26−$161M$13.5MQ2 FY26$2.5M$1.4MQ3 FY26
Latest (Q3 FY26): Net income $2.5M, Operating cash flow $1.4M.
Azenta: diluted shares by fiscal yearAzenta: diluted shares by fiscal year74MFY2074MFY2175MFY2266MFY2353MFY2446MFY25
-37.9% since FY20: buybacks shrank the count.
Azenta in its industry: growth against margin (13 companies, SIC 3559)Azenta in its industry: growth against margin (13 companies, SIC 3559)revenue growth, year over year →↑ operating marginmedian +12%median 7%LRCXACMRACLSVECOCRCTASYSVELOTRTERIIGLGISOTKCVVAZTA (+12%, -3%)
Special Industry Machinery, NEC; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Azenta

We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market. This led us to develop and provide solutions for automated ultra-cold storage. Since then, we have expanded our life sciences offerings through internal investments and through a series of acquisitions. We support our customers from research and clinical development to commercialization with our sample management and automated storage systems, as well as genomic services expertise to help our customers bring impactful therapies to market faster.

In its own words, from its 10-K, filed Dec 4, 2025.

Azenta against its Special Industry Machinery, NEC peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +12% against the peers' median +26%. Operating margin: -2.6% against the peers' median 9.9%.

CompanyQuarterRevenueY/YOp. margin
AZTA AzentaQ3 FY26$161M+12%-2.6%
LRCX LAM ResearchQ1 FY27$8.2B+54%40.0%
ACMR ACM ResearchQ3 2026$368M+37%15.1%
ACLS Axcelis TechnologiesQ3 2026$238M+11%11.5%
VECO Veeco InstrumentsQ3 2026$209M+26%6.7%
CRCT CricutQ3 2026$189M+11%18.0%
ASYS Amtech SystemsQ3 FY26$22.4M+14%9.9%
VELO Velo3DQ2 2026$20.7M+52%-53.5%
TRT Trio-Tech InternationalQ4 FY26$14.9M+40%-1.8%

Source: Azenta 10-Q on SEC EDGAR · CIK 933974 · Special Industry Machinery, NEC

13F: who owns AZTA and who is buying

Largest holders of AZTA (13F)Largest holders of AZTA (13F)BlackRock$192MVanguard Group$151MPolitan Capital Management LP$118MVanguard Portfolio Management LLC$63.6MVanguard Capital Management LLC$47.7MState Street$47.5MMassachusetts Financial Services$36.3MD. E. Shaw$34.2MMorgan Stanley$33.9MFront Street Capital Management$33.2M
Funds' net buying of AZTA by quarter (13F)Funds' net buying of AZTA by quarter (13F)−$43.5M2024-09$38.4M2024-12$52.1M2025-03$63.0M2025-06−$103M2025-09$28.8M2025-12$39.1M2026-03−$64.6M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on AZTA

History

Every quarter: Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results · Q4 FY24 results

Compare AZTA with

中文版：Azenta（AZTA）财报

Español · Français